Rac GTPase-activating protein 1 is an enzyme that in humans is encoded by the RACGAP1gene.[5]
Function
Rho GTPases control a variety of cellular processes. There are 3 subtypes of Rho GTPases in the Ras superfamily of small G proteins: RHO (see MIM 165370), RAC (see RAC1; MIM 602048), and CDC42 (MIM 116952). GTPase-activating proteins (GAPs) bind activated forms of Rho GTPases and stimulate GTP hydrolysis. Through this catalytic function, Rho GAPs negatively regulate Rho-mediated signals. GAPs may also serve as effector molecules and play a role in signaling downstream of Rho and other Ras-like GTPases.[supplied by OMIM].[6] Over-expression of RACGAP1 is observed in multiple human cancers including breast cancer,[7] gastric cancer[8] and colorectal cancer.[9] Evidence show that RACGAP1 can modulate mitochondrial quality control by stimulating mitopahy and mitochondrial biogenesis in breast cancer.[10][11] Knocking out RACGAP1 in vitro using CRISPR/Cas9 leads to cytokinesis failure.[12]
During cytokinesis, RACGAP1 has been shown to interact with KIF23 to form the centralspindlin complex.[16] This complex is essential for the formation of the central spindle. RACGAP1 also interacts with PRC1 to stabilize and maintain the central spindle as anaphase proceeds.[17] RACGAP1 can also interact with ECT2 during anaphase of cytokinesis, loss of RACGAP1 leads to cytokinesis failure.[18]
^Ren K, Zhou D, Wang M, et al. (March 2021). "RACGAP1 modulates ECT2-Dependent mitochondrial quality control to drive breast cancer metastasis". Experimental Cell Research. 400 (1): 112493. doi:10.1016/j.yexcr.2021.112493. PMID33485843. S2CID231701513.
^Saigusa S, Tanaka K, Mohri Y, et al. (January 2015). "Clinical significance of RacGAP1 expression at the invasive front of gastric cancer". Gastric Cancer. 18 (1): 84–92. doi:10.1007/s10120-014-0355-1. PMID24615626. S2CID13008506.
^Ren K, Zhou D, Wang M, et al. (March 2021). "RACGAP1 modulates ECT2-Dependent mitochondrial quality control to drive breast cancer metastasis". Experimental Cell Research. 400 (1): 112493. doi:10.1016/j.yexcr.2021.112493. PMID33485843. S2CID231701513.
^Ren K, Zhou D, Wang M, et al. (March 2021). "RACGAP1 modulates ECT2-Dependent mitochondrial quality control to drive breast cancer metastasis". Experimental Cell Research. 400 (1): 112493. doi:10.1016/j.yexcr.2021.112493. PMID33485843. S2CID231701513.
^Ren K, Zhou D, Wang M, et al. (March 2021). "RACGAP1 modulates ECT2-Dependent mitochondrial quality control to drive breast cancer metastasis". Experimental Cell Research. 400 (1): 112493. doi:10.1016/j.yexcr.2021.112493. PMID33485843. S2CID231701513.
Further reading
Maruyama K, Sugano S (January 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (October 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Kawashima T, Hirose K, Satoh T, et al. (September 2000). "MgcRacGAP is involved in the control of growth and differentiation of hematopoietic cells". Blood. 96 (6): 2116–24. doi:10.1182/blood.V96.6.2116. PMID10979956.